Market revenue in 2023 | USD 24.8 million |
Market revenue in 2030 | USD 251.3 million |
Growth rate | 39.2% (CAGR from 2023 to 2030) |
Largest segment | C.difficle |
Fastest growing segment | C.difficle |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | C.difficle, Crohns disease, IBS, Diabetes |
Key market players worldwide | Carbios SA, Boise Cascade Co, Assembly Biosciences Inc, Wacker Chemie AG, SGS AG, Lonza Group Ltd, Arranta Bio, 4D Pharma, NIZO, Inpac Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to live biotherapeutic products and microbiome cdmo market will help companies and investors design strategic landscapes.
C.difficle was the largest segment with a revenue share of 86.29% in 2023. Horizon Databook has segmented the North America live biotherapeutic products and microbiome cdmo market based on c.difficle, crohns disease, ibs, diabetes covering the revenue growth of each sub-segment from 2018 to 2030.
The market is driven by the presence of established CDMOs, increasing number of clinical trials, and growing prevalence of C. difficile, Irritable Bowel Syndrome (IBS), & Crohn’s disease in North America.
In the region, the U.S. is the biggest market for Live Biotherapeutic Products (LBPs) and microbiomes, as several biopharmaceuticals and pharmaceutical companies prefer outsourcing their preclinical trials to CDMOs based in the U.S. Increasing investments in R&D by market players and government support for clinical trials also promote market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America live biotherapeutic products and microbiome cdmo market , including forecasts for subscribers. This continent databook contains high-level insights into North America live biotherapeutic products and microbiome cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account